Researchers at The Wistar Institute have determined the three-dimensional structure of a key two-molecule complex involved in long-term gene storage, primarily in non-growing cells. This discovery provides important insights into how cells protect genes that could trigger cancers and other disorders.
Researchers at The Wistar Institute have identified a single molecule required for genome compaction in spores and sperm, a process critical for passing genetic information to offspring. Compaction helps protect the genome from damage and is essential for maintaining fertility in higher organisms.
A new study outlines an innovative approach to create a CMV vaccine using recombinant technologies. Researchers have successfully introduced human CMV genes into mouse CMV, resulting in a novel form of the virus that can trigger an immune response without sustaining infection.
Researchers at The Wistar Institute successfully determined the three-dimensional structure of the p53 protein bound as a dimer to DNA, revealing new insights into its anti-cancer activity. The study's findings suggest that the interface between the two proteins in the dimer is crucial for proper functioning and binding to DNA.
Researchers found that a gene-regulating enzyme is targeted by certain monoamine oxidase inhibitors used to treat depression. These drugs, such as tranylcypromine, may also have anti-cancer activity due to their ability to inhibit the growth of cancer cells.
Breakthroughs in melanoma research suggest optimism for future cures, with artificial skin models enabling the study of tumor interactions and immune system responses. A novel vaccine approach also shows promise in treating melanoma by stimulating killer T cells to attack cancerous cells.
Researchers have identified a new global mechanism for gene repression, using histones and the SUMO protein to silence genes. The study found that sumoylation occurs near telomeres and is involved in maintaining genomic stability.
A study published in Nature Genetics found that precancerous tumors with diverse cell populations are more likely to evolve into cancer. The research suggests that genetic diversity could serve as a biomarker for cancer risk, and may help doctors assess the success of cancer prevention therapies.
Researchers developed a vaccine strategy using the BRAFV600E peptide to stimulate killer T cells, showing potential for treating approximately a third of melanoma patients. The approach's specificity reduces toxicity and targets only cancer cells.
Researchers discover precursor miRNAs undergo specific RNA editing, suppressing expression and activity. This finding expands our understanding of the complex process of gene regulation, with implications for embryonic development, cell differentiation, and cancer formation.
A new study published in Cell identifies RISC as a three-protein complex responsible for microRNA production and specificity in gene silencing. The complex, consisting of Dicer, Argonaute 2, and TRBP enzymes, oversees the creation of microRNAs and guides them to target specific messenger RNAs.
Researchers at The Wistar Institute have identified a novel multi-protein complex called the Integrator that plays a central role in processing small nuclear RNAs. This complex, which consists of at least 12 subunits, appears to bind to both CTD and specific genes coding for snRNAs.
Scientists at The Wistar Institute have identified the cancer gene MYC as activating the metastasis gene MTA1, a key regulator of tumor spread. Blocking this pathway may prevent metastasis and inform the development of new therapies.
A new study by The Wistar Institute reveals that a recently discovered enzyme requires molecular partners to modify histones and repress genes in neurons. The findings may have long-term implications for treating depression and other psychiatric disorders.
Scientists at The Wistar Institute discovered that poor T cell responsiveness limits current approaches to therapeutic vaccines. They found that the immune system's ongoing stimulus during chronic infection prevents optimal response to vaccines, which may be improved by lowering viral load or enhancing T cell function.
A new study by The Wistar Institute has identified a three-protein complex responsible for producing mature miRNAs in the cell cytoplasm. This complex is associated with Argonaute 2, which plays a crucial role in gene silencing. The research also links miRNA production to HIV replication and tumor suppression.
The 2005 Wistar Institute Science Journalism Award was awarded to Hall for his novel exploration of human life conceived with artificial reproductive assistance. The award recognizes intelligent and perceptive journalism that communicates progress in biomedicine to the public.
Researchers at The Wistar Institute found that an initiating genetic error can lead to relentless cell division, causing DNA replication stress and breaks. This stress creates conditions for tumor progression and the accumulation of mutant genes, ultimately leading to cancer.
A study led by The Wistar Institute discovered that the enzyme Ubp10 plays a crucial role in protecting the genome's telomeric regions from destabilization. This protection may help prevent genetic recombinations that can trigger cancer or accelerate aging.
Research suggests a common viral lineage among viruses infecting hosts from all three domains of life, based on structural similarities in their coats. The study found that these similarities may point to sites of enzymatic activity that could be targeted with anti-viral drugs.
A new study from The Wistar Institute identified a microprocessor complex essential for miRNA production, linking it to DiGeorge syndrome and potentially schizophrenia. The discovery provides insights into the processing mechanisms of miRNAs and may lead to future investigations into these disorders.
Researchers at The Wistar Institute have identified a protein called 53BP1, which recognizes molecular sites in chromatin to detect DNA breaks. This protein is responsible for activating the p53 cell-death program, preventing cancer, and has been found to work through a specific mechanism involving nucleosome structure.
A new Wistar Institute study suggests that epigenetic information can be passed from generation to generation, complicating the standard model of genetics. The research findings support the theories of Jean-Baptiste Lamarck, who proposed that traits acquired by parents during their lives could be passed on to offspring.
Researchers found that human p53 and Cep-1, a roundworm protein, bind to similar DNA sequences in their respective genomes but in different conformations. The study suggests that both proteins exist primarily as tetramers under normal circumstances, leading to a new understanding of how they interact with DNA.
A new triple-vaccine strategy has been shown to stimulate a strong HIV-specific immune response in monkeys, demonstrating its potential as an improved method of protection against the virus. The approach uses a series of three vaccines that build on each other to generate a stronger immune response than might otherwise be possible.
A new study by The Wistar Institute suggests that the MYC protein binds to a large percentage of genes without activating them. This discovery raises questions about MYC's other functions and potential tissue-specific controls.
Scientists at The Wistar Institute discovered a binding site that, if blocked, could activate the protein to promote genomic stability and decrease cancer. By analyzing the molecular details of how sirtuins work, researchers identified potential activators using virtual libraries of molecules.
The Wistar Institute has selected two journalists, Ambrose and Gibbs, for the 2004 Science Journalism Award for their outstanding coverage of epigenetics. The award honors excellent science journalism that communicates progress in biomedicine to the public.
Researchers have discovered that insect-derived antimicrobial peptides, such as pyrrhocoricin, can penetrate human dendritic cells and fibroblasts, potentially leading to new vaccine and immune therapies. The peptides are being explored as drug-delivery vehicles for peptide or peptide-based drugs that normally cannot cross cell membranes.
A Wistar Institute-led team will develop blood tests to detect early lung cancer using proteomics and genomics, aiming to save lives through earlier cancer detection. The project receives $3.4M in funding from Pennsylvania's share of the national tobacco settlement.
The award honors intelligent and perceptive journalism on biomedical research, with a focus on accessibility and impact. Up to five stories can be submitted by individual journalists or teams, with a deadline of February 29, 2004.
Researchers discovered two new proteins, BRCC36 and RCC45, that are part of the BRCC complex and linked to sporadic breast cancers. The complex regulates DNA repair and cell division, influencing cancer susceptibility.
A new study by researchers at The Wistar Institute shows that gene activation is a highly dynamic process requiring specific molecular modifications, including the addition and removal of ubiquitin. This process involves a sequence of events and not just the accumulation of molecular groups.
Researchers at The Wistar Institute report new insights into the role of sirtuins in gene expression, revealing a mechanism likely to be general for the entire sirtuin enzyme family. This discovery may offer an explanation for the connection between metabolism and aging.
Researchers developed vaccines based on human and chimpanzee adenoviruses to protect newborns against viral diseases. These oral vaccines have the potential to be effective even with waning maternal antibodies, offering a crucial solution for infants in developing countries.
Researchers at The Wistar Institute have provided new insights into the emerging theory of gene regulation, showing how two enzymes work together to activate specific genes by loosening chromatin. This study supports the 'histone code' theory, suggesting complex modifications to histones control gene activity.
Researchers at The Wistar Institute have discovered a new mechanism for gene silencing that involves multiple enzymes and histone modifications. This discovery could lead to the development of new cancer therapies by re-silencing inappropriately activated genes.
A structured stop-and-start drug regimen could extend care to more patients in resource-poor countries while reducing HIV drug toxicity. However, the high cost of drugs needed for the study poses a significant challenge to its success.
Researchers at The Wistar Institute developed DNA arrays to accurately diagnose Sezary syndrome, a leukemic variant of cutaneous T-cell lymphoma. The technology identified genetic markers that can predict patient survival and identify potential drug targets.
A novel flu vaccine developed by The Wistar Institute has generated a strong antibody response in mice, offering hope for a more stable and effective vaccine. The vaccine targets a stable region of the virus, potentially providing long-term protection against flu strains.
Researchers at The Wistar Institute have discovered a family of molecular complexes involved in the repression of extensive sets of tissue-specific genes. These complexes share two core subunits, including histone deacetylase and BHC110, which operate as co-repressors to maintain gene silencing.
A new vaccine based on a chimpanzee adenovirus has shown promise against HIV by inducing a powerful T-cell-based immune response in mice. The vaccine avoids the issue of pre-existing immunity seen with human adenovirus vaccines.
The Wistar Institute's MAb425 antibody has shown promising results in a Drexel University trial, with three high-grade tumor patients alive after five years and eight lower-grade tumor patients surviving for 56 months or longer.
Scientists have identified a unique mechanism used by the Esa1 enzyme to relax DNA packaging, differing from other enzymes in its family. This discovery opens up new possibilities for developing targeted cancer therapies.
Researchers have discovered a new viral structure that suggests a continuum in the evolution of viruses, revealing similarities between PRD1 and human adenoviruses. The findings provide insights into the evolutionary path taken by families of viruses and may lead to the development of new therapies for certain infections.
A new study has found that a second set of immune cells, known as regulatory T cells, prevent attack cells from acting against cancer. The study discovered that these regulatory T cells communicate with the attack cells via a messenger chemical called TGF-beta.
Scientists identify a new mechanism by which cohesins bind to DNA, revealing the role of Alu sequences in gene regulation. The discovery sheds light on developmental disorders and cancer, offering potential avenues for research and treatment.
Researchers at The Wistar Institute have discovered a link between neurofibromatosis and Alzheimer's disease, with the shared protein kinesin-1 playing a pivotal role in protein trafficking. This finding opens new avenues for investigation into both diseases, providing insights into vital cellular processes.
Scientists at The Wistar Institute identified key segments of an insect-derived antimicrobial peptide that kill bacteria and prevent mammalian cell entry. The research team confirmed the peptide's binding site on a bacterial protein target, opening up possibilities for novel antibiotic design and universal drug delivery.
The study found that a critical balance exists between T helper cells and regulatory T cells in preventing autoimmunity. Regulatory T cells can suppress the development of autoimmunity in lupus-prone mice, suggesting a potential new approach to treating autoimmune disorders.